Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review

Radiation therapy (RT) evolved to be a primary treatment modality for cancer patients. Unfortunately, the cure or relief of symptoms is still accompanied by radiation-induced side effects with severe acute and late pathophysiological consequences. Inhibitors of cyclooxygenase-2 (COX-2) are potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Laube, Markus, Kniess, Torsten, Pietzsch, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931535/
https://www.ncbi.nlm.nih.gov/pubmed/27104573
http://dx.doi.org/10.3390/antiox5020014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931535/
https://www.ncbi.nlm.nih.gov/pubmed/27104573
http://dx.doi.org/10.3390/antiox5020014

Ejemplares similares